Senior Scientist, Process Development - Bioconjugation
Senior scientist leading process development and tech transfer for oligonucleotide conjugates across preclinical to GMP production.
- Full Time
- $147,000 – $180,000/year
- Min. 5 YOE
Browse the full live job inventory for Dyne Therapeutics. This page is focused on current openings, while the overview tab highlights role groups and hiring patterns.
Senior scientist leading process development and tech transfer for oligonucleotide conjugates across preclinical to GMP production.
Strategic field medical leader engaging KOLs, developing regional medical plans to drive patient outcomes.
Lead engineering strategy and implementation for bioprocess and bioconjugation manufacturing at clinical and commercial scales.
Lead strategy and execution to define, substantiate, and communicate value of medicines, shaping HTA and payer engagement.
Leads development and execution of imaging biomarker strategies to support clinical trials and regulatory submissions.
Lead US Affiliate business operations, budgeting, governance, and cross‑functional initiatives to enable the first U.S. product launch.
Leads global managed access programs, aligning MAPs with mission while driving data-driven optimization and stakeholder collaboration.
Leads training strategy and execution across field-facing teams to enable effective onboarding and ongoing development in neuroscience and rare-disease commercial functions.
Drives market insights and forecasting for first product launches in rare neuromuscular diseases, aligning data analytics with brand strategy.
Lead formulation/development efforts for bioconjugate drug products, ensuring manufacturability, quality, and stability across clinical stages.
Lead analytical development for bioconjugates, manage external CMOs/CTLs, and expand internal AD/CMC lab.
Lead nonclinical safety planning and regulatory documentation for antibody/oligonucleotide therapeutics across preclinical to first-in-human studies.
Leads GMP quality operations for external and internal GMP activities, ensuring compliant QA deliverables and inspection readiness.
Lead publication and medical education endeavors for DMD program, coordinating cross-functional medical communications and materials.
Establishes and leads marketing operations with launch readiness focus across DMD and DM1 assets; builds systems and processes for compliant, efficient therapeutic education delivery.
Drive patient advocacy strategy and operational execution across partnerships, grants, events, and contracting.
Lead cross-functional teams to execute program strategy and plan delivery across multiple molecules.
TMF operations, quality, and inspection readiness to ensure compliant, inspection-ready TMF across studies.
Leads global scientific communications strategy for DMD, integrating preclinical, clinical, and real-world data into publications and education materials.
Leads global CMC regulatory strategies across development stages, ensuring compliant submissions and lifecycle management.
Lead CMC regulatory execution for programs; develop regulatory strategies aligning with Manufacturing and Quality, coordinating global submissions.
Leads US medical strategy and launch readiness, KOL engagement, and RWE initiatives to support product introduction.
Leads nationwide field organization to deliver Dyne’s therapies; builds strategy and launches in rare diseases with cross-functional alignment.
Lead design and implementation of a global health care compliance program for a first-launch biotech, guiding policies, training, audits, and investigations.